SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950134-07-016734
Filing Date
2007-08-03
Accepted
2007-08-03 14:17:05
Documents
8
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f32364e10vq.htm 10-Q 323857
2 EXHIBIT 10.32 f32364exv10w32.htm EX-10.32 656748
3 EXHIBIT 31.1 f32364exv31w1.htm EX-31.1 9163
4 EXHIBIT 31.2 f32364exv31w2.htm EX-31.2 9181
5 EXHIBIT 32.1 f32364exv32w1.htm EX-32.1 4565
6 EXHIBIT 32.2 f32364exv32w2.htm EX-32.2 4587
7 GRAPHIC f32364f3236401.gif GRAPHIC 5144
8 GRAPHIC f32364f3236400.gif GRAPHIC 4749
  Complete submission text file 0000950134-07-016734.txt   1023465
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50577 | Film No.: 071023519
SIC: 2834 Pharmaceutical Preparations